Clinical and pharmacological group: & nbsp

NSAIDs - Derivatives of acetic acid and related compounds

Included in the formulation
  • Indocollar
    drops d / eye 
    VALEANT, LLC     Russia
  • Indomethacin
    ointment externally 
    VetProm AD     Bulgaria
  • Indomethacin
    ointment externally 
    ATOLL, LLC     Russia
  • Indomethacin
    pills inwards 
    ATOLL, LLC     Russia
  • Indomethacin
    ointment externally 
  • Indomethacin
    pills inwards 
  • Indomethacin
    ointment externally 
  • Indomethacin
    ointment externally 
    BIOSINTEZ, PAO     Russia
  • Indomethacin
    gel externally 
    Balkanfarm - Troyan AD     Bulgaria
  • Indomethacin
    suppositories rect. 
    FARMAPRIM, LLC     The Republic of Moldova
  • Indomethacin
    suppositories rect. 
    BIOSINTEZ, PAO     Russia
  • Indomethacin 100 Berlin-Chemie
    suppositories rect. 
    BERLIN-PHARMA, CJSC     Russia
  • Indomethacin 50 Berlin-Chemie
    suppositories rect. 
    BERLIN-PHARMA, CJSC     Russia
  • Indomethacin Sopharma
    suppositories rect. 
    Sopharma, AO     Bulgaria
  • Indomethacin Sopharma
    pills inwards 
    Sopharma, AO     Bulgaria
  • Indomethacin Sopharma
    ointment externally 
    Sopharma, AO     Bulgaria
  • Indomethacin-Acry®
    ointment externally 
    AKRIKHIN HFK, JSC     Russia
  • Indomethacin-Altpharm
    suppositories rect. 
    ALTFARM, LLC     Russia
  • Indomethacin-Biosynthesis
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Metindole retard
    pills inwards 
  • АТХ:

    C.01.E.B.03   Indomethacin

    S.01.B.C.01   Indomethacin

    M.02.A.A.23   Indomethacin

    Pharmacodynamics:

    Non-selectively suppresses COX1 and COX2, regulating the synthesis of prostaglandins. Has analgesic, antipyretic and anti-inflammatory effect.

    Reduces thrombosis, aggregation and adhesion of platelets, suppressing the synthesis of thromboxane A2 in thrombocytes.

    Pharmacokinetics:

    After oral administration, it is completely absorbed in the gastrointestinal tract. The maximum concentration in the blood plasma is reached after 2 hours. It binds to blood plasma proteins by 99% and accumulates in the focus of inflammation. Penetrates through the blood-brain and placental barrier, into breast milk. It is not removed during hemodialysis.

    Metabolism in the liver.

    The half-life is 4.5 hours.

    Elimination by the kidneys (60%) and with feces (40%) in the form of metabolites.

    Indications:

    Used internally with chronic rheumatoid arthritis, psoriatic arthritis, Bechterew's disease, myositis, thrombophlebitis of superficial veins.As an adjuvant, it is used for inflammatory diseases of the ENT organs, prostatitis, cystitis, adnexitis, and also for analgesia with dysmenorrhea.

    Used for topical application to prevent inflammation after surgical interventions for cataract and for inhibition of miosis.

    It is applied externally for the treatment of articular syndrome, pain in the spine, neuralgia, myalgia, traumatic affection of joints and soft tissues.

    VII.H25-H28.H25   Star cataract

    VII.H25-H28.H26   Other cataracts

    XIII.M05-M14.M05   Seropositive rheumatoid arthritis

    XIII.M05-M14.M08   Juvenile [juvenile] arthritis

    XIII.M05-M14.M10   Gout

    XIII.M15-M19.M15   Polyarthrosis

    XIII.M45-M49.M45   Ankylosing spondylitis

    XIII.M50-M54.M54.1   Radiculopathy

    XIII.M70-M79.M79   Other diseases of soft tissues, not elsewhere classified

    XIII.M70-M79.M79.1   Myalgia

    XIII.M70-M79.M79.2   Neuralgia and neuritis, unspecified

    XIV.N30-N39.N30   Cystitis

    XIV.N70-N77.N70   Salpingitis and oophoritis

    XIV.N80-N98.N94.4   Primary dysmenorrhea

    XIV.N80-N98.N94.5   Secondary dysmenorrhea

    Contraindications:

    Peptic ulcer of stomach and duodenum, violation of blood coagulation and hematopoiesis, hyperkalemia.

    Individual intolerance to non-steroidal anti-inflammatory drugs and aspirin.

    Carefully:

    Children under the age of 12 with hyperthermia on the background of viral infections are a danger of developing Reye's syndrome. Chronic heart failure, active inflammatory processes of the liver, chronic renal failure, the use of diuretics. Hemophilia, systemic lupus erythematosus. Hypersensitivity.

    Pregnancy and lactation:

    Pregnancy and lactation: recommendations on the FDA - Category C. The use during pregnancy is contraindicated in the III trimester. In I and II trimesters, as well as during lactation indomethacin is prescribed in situations where the risk from taking the drug is lower than the expected efficacy.

    Dosing and Administration:

    Use in children

    Inside to 2 mg / kg per day in 3 divided doses.

    Adults

    Inside: 25-50 mg 2-3 times a day.

    Locally: in the form of ointment 2 times a day; to eliminate miosis in ophthalmic operations - 4 drops a day before the operation, and 4 drops 3 hours before the operation; with the goal of preventing postoperative edema - 1 drop 4-6 times a day.

    The highest daily dose: 200 mg.

    The highest single dose: 50 mg.

    Side effects:

    Central and peripheral nervous system: dizziness, agitation, headache, depression, cognitive disorders, sleep disorders, tremor, paresthesia, aseptic meningitis.

    The cardiovascular system: arterial hypertension, tachycardia.

    Hemopoietic system: leukopenia, thrombocythemia, agranulocytosis, aplastic anemia.

    Digestive system: gastralgia, dyspeptic disorders, anorexia, melena, constipation.

    Sense organs: diplopia, visual impairment, deafness.

    urinary system: peripheral edema, proteinuria.

    Allergic reactions.

    Overdose:

    Increased side effects, hyperventilation of the lungs, convulsive alertness.

    Treatment is symptomatic.

    Interaction:

    Not compatible with alcohol.

    Increases the concentration in the plasma digoxin, phenylalanine, lithium preparations.

    Reduces the effectiveness of diuretics and antihypertensive drugs.

    Increases the toxicity of methotrexate - recommended interval between taking drugs in 24 hours.

    The concentration of the drug in the blood plasma is reduced with the simultaneous use of acetylsalicylic acid.

    Changes the effect of oral hypoglycemic drugs: hypo- or hyperglycemia.

    Special instructions:

    It can slow down the reaction rate when driving vehicles and controlling machinery.

    Instructions
    Up